Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Inventory (2016 - 2025)

Jaguar Health (JAGX) has disclosed Inventory for 11 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Inventory fell 16.88% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Dec 2025, down 16.88% year-over-year, with the annual reading at $8.6 million for FY2025, 16.88% down from the prior year.
  • Inventory for Q4 2025 was $8.6 million at Jaguar Health, down from $10.6 million in the prior quarter.
  • The five-year high for Inventory was $10.7 million in Q2 2025, with the low at $2.8 million in Q1 2021.
  • Average Inventory over 5 years is $7.7 million, with a median of $8.5 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 103.38% in 2021, then decreased 16.88% in 2025.
  • Over 5 years, Inventory stood at $4.9 million in 2021, then soared by 43.35% to $7.0 million in 2022, then surged by 30.82% to $9.2 million in 2023, then increased by 12.58% to $10.3 million in 2024, then dropped by 16.88% to $8.6 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $8.6 million, $10.6 million, and $10.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.